• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, July 12, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • FIFA World Cup
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Staff Report

NAB arrests top bureaucrat in illegal drugs price hike case

Published on: November 25, 2016 5:58 AM

ISLAMABAD: NAB Rawalpindi has arrested Arshad Farooq Faheem (The then Chairman Drugs Pricing Committee, DRAP) Additional Secretary (BPS-21) Wafaqi Mohtasib Secretariat in the mega corruption drug case. The accused person gave wrongful financial benefits to eight pharmaceutical companies /firms in the shape of illegal price increase of their drugs causing loss to the public at large to the tune of Rs. 1078.08 million out of which an amount of Rs. 400 million has already been recovered.

In the same case, NAB has already arrested eight accused persons namely Dr. Muhammad Ali (The then Secretary cum Member Drugs Pricing Committee), Ex member pricing (BPS-21) DRAP, Ahsan Feroze, Director of M/s Maple Pharmaceuticals (Pvt) Ltd, Arif Aziz Akhai, proprietor M/s Akhai Agencies, Amir Saddique, Director of Excel Health Care Laboratories (Pvt) Ltd, Saif-ur-Rehman & Khalil-ur-Rehman, Directors of M/s Galaxy Pharma (Pvt) Ltd, Rizwan Umer & Muqtadir MA Javaid, Directors of M/s Martin Dow Ltd. They were produced before the Judge Accountability Court, Islamabad where a 10-day physical remand had been granted for investigation.

As per investigation report, the NAB Rawalpindi submitted in the court that the members of Drug Pricing Committee in connivance with beneficiary Pharma companies / firms extended undue financial benefits to pharmaceutical companies / firms in the shape of illegal and unjustified price increase of their drugs through a DPC meeting held on 09-10-2012 & 22-01-2013 and a sub-committee meeting held on 19-11-2012.

The wrongful financial benefits derived by the eight pharmaceutical companies / firms on the basis of price increase through afore mentioned meetings comes to be Rs. 1078.08 M appox till 30-6-2015. This illegal benefit is perpetually being gained by the pharmaceutical companies / firms who submitted inflated invoices / incorrect / incomplete costing data and were selling their drugs at prices which were illegally increased by the members of DPC.

During the process of Investigation, it revealed that the Pharmaceutical companies in connivance with accused Officers/ Officials submitted incomplete/incorrect and inflated invoices to DRAP for fixation of drugs prices at exorbitant rates.

Due to an illegal price hike in the DPC meetings held on 09-10-2012 & 22-01-2013 and sub-committee meeting held on 19-11-2012 approx Rs. 1078.08 million has been pocketed by these Pharmaceutical companies causing an unbearable burden on the general public.

In this case, two accused persons namely Tariq Haider and Mian Muhammad Khalid were arrested but released by the Accountability Court after payment of their liability of Rs. 385.12 million and Rs. 15 million from the directors of M/s Saffron Pharmaceuticals Pvt Ltd.

Filed Under: Islamabad

Submit a Comment




Primary Sidebar




Latest News

North Korea nuclear disarmament

North Korea Says Nuclear Disarmament Should Begin with U.S. Allies

PMD issues Glof alert for GB, KP as fresh westerly wave approaches

Pakistan can’t afford unchecked population growth, warns Bilawal

Population and development deeply interconnected: Zardari

Memon welcomes Sindh-Centre synergy to address climate-related hazards

Pakistan

PMD issues Glof alert for GB, KP as fresh westerly wave approaches

Pakistan can’t afford unchecked population growth, warns Bilawal

Population and development deeply interconnected: Zardari

Memon welcomes Sindh-Centre synergy to address climate-related hazards

Valika Hospital HIV tally reaches 80 as two more children test positive

More Posts from this Category

Business

Petrol, diesel prices rise by Rs13

Digital assets, Sharia status discussed in meeting

Pakistan to receive $3.6bn from IMF

Gold price rises Rs1,100 per tola in Pakistan

World Bank approves $376m to boost Pakistan’s electricity grid

More Posts from this Category

World

North Korea nuclear disarmament

North Korea Says Nuclear Disarmament Should Begin with U.S. Allies

Typhoon Bavi

Typhoon Bavi Expected to Make Landfall on China’s Eastern Coast

Missouri flooding

Missouri Declares Emergency as Severe Flooding Submerges Communities

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}